Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Quiros-Roldan

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
Journal of Medical Virology|July 20, 2004
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patientsCarlo Torti, Eugenia Quiros-Roldan, Laura Monno, et al.
Journal of Clinical Medicine|December 23, 2022
Syphilis Infections, Reinfections and Serological Response in a Large Italian Sexually Transmitted Disease Centre: A Monocentric Retrospective StudyValentina Marchese, Giorgio Tiecco, Samuele Storti, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Current HIV Research|February 13, 2014
Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patientsSilvia Amadasi, Silvia Odolini, Emanuele Foca, et al.
Andrology|March 9, 2026
SIEDY Diagnostic Accuracy in Assessing Erectile Dysfunction in Young Men Living With HIVGiorgio Tiecco, Federico Cesanelli, Cosimo Colangelo, et al.
Life (Basel, Switzerland)|April 26, 2025
Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological ImplicationsMaria Antonia De Francesco, Franco Gargiulo, Francesca Dello Iaco, et al.
European Journal of Medical Research|August 18, 2023
Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohortShannan N Rich, Paola Nasta, Eugenia Quiros-Roldan, et al.
AIDS Care|June 21, 2016
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012Eugenia Quiros-Roldan, Elena Raffetti, Emanuele Focà, et al.
AIDS and Behavior|March 6, 2022
Psychological and Emotional Impact of COVID-19 Pandemic on People Living with Chronic Disease: HIV and CancerEmanuele Focà, Chiara Fornari, Stefania Arsuffi, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trialFrancesca Lombardi, Simone Belmonti, Eugenia Quiros-Roldan, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Journal of Medical Virology|July 20, 2004
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patientsCarlo Torti, Eugenia Quiros-Roldan, Laura Monno, et al.
Journal of Clinical Medicine|December 23, 2022
Syphilis Infections, Reinfections and Serological Response in a Large Italian Sexually Transmitted Disease Centre: A Monocentric Retrospective StudyValentina Marchese, Giorgio Tiecco, Samuele Storti, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Current HIV Research|February 13, 2014
Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patientsSilvia Amadasi, Silvia Odolini, Emanuele Foca, et al.
Andrology|March 9, 2026
SIEDY Diagnostic Accuracy in Assessing Erectile Dysfunction in Young Men Living With HIVGiorgio Tiecco, Federico Cesanelli, Cosimo Colangelo, et al.
Life (Basel, Switzerland)|April 26, 2025
Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological ImplicationsMaria Antonia De Francesco, Franco Gargiulo, Francesca Dello Iaco, et al.
European Journal of Medical Research|August 18, 2023
Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohortShannan N Rich, Paola Nasta, Eugenia Quiros-Roldan, et al.
AIDS Care|June 21, 2016
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012Eugenia Quiros-Roldan, Elena Raffetti, Emanuele Focà, et al.
AIDS and Behavior|March 6, 2022
Psychological and Emotional Impact of COVID-19 Pandemic on People Living with Chronic Disease: HIV and CancerEmanuele Focà, Chiara Fornari, Stefania Arsuffi, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trialFrancesca Lombardi, Simone Belmonti, Eugenia Quiros-Roldan, et al.
Pageof 21